Impact Factor
3.90
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.77
1,063 total citations
h5-index
37
h5 depth signal
Cited share
86.1%
199 of 231
Total citations
1,063
Citation footprint
Metric signal
4.21
External metric anchor
Self-citation
0.8%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
384
Italy
262
United Kingdom
122
Canada
90
Germany
75
Citing Fields of Research
Neurodegenerative Disorders
280
Brain Neurological Disorders
220
Psychiatry
212
Neurosciences
156
Neuromuscular Disorders
145
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,376
Articles tracked across the journal lifetime
Indexed publication set
231
199 cited publications
Last 12 months
107
8.9 publications/month
Open access share
29.0%
31 OA publications in the last year
Leading citing country
United States
384 citing publications
Leading citing field
Neurodegenerative Disorders
280 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Jan. 2004-
v4n1, Jan. 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Migraines & Headaches
Psychiatry
Brain Neurological Disorders
Neuromuscular Disorders
Broad Categories
Neurology
Therapeutics
Neurodegenerative Disorders
Psychiatry
Brain Neurological Disorders
Migraines & Headaches
Musculoskeletal Disorders
Postural Control
MeSH Descriptors
Central Nervous System Diseases
Central Nervous System
Mental Disorders
Neuropharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/14737175.2026.2749652
Open DOI
Recent advances in the management of Lewy body dementia: evaluating progress and future directions
1. Lewy body dementia (LBD), encompassing Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB), is a progressive and clinically heterogeneous disorder that significantly affects p...
02
DOI 10.1080/14737175.2026.2748281
Open DOI
Diagnostic evolution of carbonic anhydrase 3 (CA3) in Amyotrophic Lateral Sclerosis (ALS): an emerging prognostic biomarker
03
DOI 10.1080/14737175.2026.2744756
Open DOI
Current and emerging neuromodulation techniques for motor recovery after ischemic stroke: a 2026 update
04
DOI 10.1080/14737175.2026.2744752
Open DOI
When sex matters early: clues from pediatric onset multiple sclerosis
05
DOI 10.1080/14737175.2026.2744754
Open DOI
DT120 (MM120): a single-dose orally disintegrating formulation of lysergide tartrate for generalized anxiety disorder
06
DOI 10.1080/14737175.2026.2723909
Open DOI
Precision cognitive neurorehabilitation: dose, adaptivity, digital therapeutics and implementation
07
08
DOI 10.1080/14737175.2026.2742388
Open DOI
Contemporary approaches to Sydenham’s chorea - where evidence meets reality
09
DOI 10.1080/14737175.2026.2737272
Open DOI
Focused ultrasound blood-brain barrier opening: a review of post-procedure MRI outcomes
1. The blood-brain barrier (BBB) is a selectively permeable barrier between the central nervous system (CNS) and the systemic circulation. The principal components of the BBB are CNS microvascular ...
10
DOI 10.1080/14737175.2026.2733194
Open DOI
Plain language summary of the mechanisms behind epilepsy in Alzheimer’s disease and the use of perampanel
Bibliographical & Catalog Notes
Title from cover.
Vol. 1 complete in 2 no.
Also available online.
Also published in Polish.